Item Type | Name |
Academic Article
|
Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.
|
Academic Article
|
beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.
|
Academic Article
|
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
|
Academic Article
|
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
|
Academic Article
|
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
|
Academic Article
|
Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
|
Academic Article
|
Are women ready for the HPV vaccine?
|
Academic Article
|
Practice patterns of SGO members for stage IIIA endometrial cancer.
|
Academic Article
|
Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
|
Academic Article
|
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
|
Academic Article
|
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
|
Academic Article
|
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
|
Academic Article
|
STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.
|
Academic Article
|
Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome.
|
Academic Article
|
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
|
Academic Article
|
Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromes.
|
Academic Article
|
Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
|
Academic Article
|
Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
|
Academic Article
|
Prospective evaluation of insulin resistance among endometrial cancer patients.
|
Academic Article
|
Genetic variants in TGF-? pathway are associated with ovarian cancer risk.
|
Academic Article
|
The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
|
Academic Article
|
Enhanced estrogen-induced proliferation in obese rat endometrium.
|
Academic Article
|
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.
|
Academic Article
|
Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
|
Concept
|
Genital Neoplasms, Female
|
Concept
|
Genital Diseases, Female
|
Concept
|
Female
|
Academic Article
|
A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.
|
Academic Article
|
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
Academic Article
|
Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.
|
Academic Article
|
Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome.
|
Academic Article
|
A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.
|
Academic Article
|
Early detection of ovarian cancer: promise and reality.
|
Academic Article
|
Grading ovarian serous carcinoma using a two-tier system.
|
Academic Article
|
Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
|
Academic Article
|
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
|
Academic Article
|
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.
|
Academic Article
|
Endometrial cancer in young, normal-weight women.
|
Academic Article
|
Association between adiponectin, insulin resistance, and endometrial cancer.
|
Academic Article
|
Women with HNPCC: a target population for the chemoprevention of gynecologic cancers.
|
Academic Article
|
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
|
Academic Article
|
Endometrial cancer associated with defective DNA mismatch repair.
|
Academic Article
|
Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
|
Academic Article
|
Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer.
|
Academic Article
|
Accuracy of the BRCAPRO model among women with bilateral breast cancer.
|
Academic Article
|
Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.
|
Academic Article
|
Preventing future cancers by testing women with ovarian cancer for BRCA mutations.
|
Academic Article
|
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
|
Academic Article
|
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma.
|
Academic Article
|
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.
|
Academic Article
|
Genotype in BRCA-associated breast cancers.
|
Academic Article
|
Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention.
|
Academic Article
|
CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.
|
Academic Article
|
Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
|
Academic Article
|
Outcome of pregnancies occurring within 1 year of hydatidiform mole.
|
Academic Article
|
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
|
Academic Article
|
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
|
Academic Article
|
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
|
Academic Article
|
Commenting on "HER2/neu overexpression: has the Achilles' heel of uterine serous papillary carcinoma been exposed? (88:263-5) by Santin AD".
|
Academic Article
|
Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome.
|
Academic Article
|
Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
|
Academic Article
|
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
|
Academic Article
|
An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients.
|
Academic Article
|
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
|
Academic Article
|
Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas.
|
Academic Article
|
Update on the management of ovarian germ cell tumors.
|
Academic Article
|
Prevention and early detection of ovarian cancer: mission impossible?
|
Academic Article
|
Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
|
Academic Article
|
Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy.
|
Academic Article
|
Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
|
Academic Article
|
Genetic polymorphisms and endometrial cancer risk.
|
Academic Article
|
Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
|
Academic Article
|
What women with ovarian cancer think and know about genetic testing.
|
Academic Article
|
Management of early-stage endometrial cancer.
|
Academic Article
|
Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome.
|
Academic Article
|
The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention.
|
Academic Article
|
Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.
|
Academic Article
|
Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome.
|
Academic Article
|
Expanding the criteria for BRCA mutation testing in breast cancer survivors.
|
Academic Article
|
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.
|
Academic Article
|
Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health Study.
|
Academic Article
|
A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges.
|
Academic Article
|
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.
|
Academic Article
|
Testing women with endometrial cancer to detect Lynch syndrome.
|
Academic Article
|
Understanding obesity and endometrial cancer risk: opportunities for prevention.
|
Academic Article
|
Earlier age of onset of BRCA mutation-related cancers in subsequent generations.
|
Academic Article
|
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
|
Academic Article
|
Chemopreventive effects of metformin on obesity-associated endometrial proliferation.
|
Academic Article
|
Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
|
Academic Article
|
Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist.
|
Academic Article
|
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.
|
Academic Article
|
Response to an exercise intervention after endometrial cancer: differences between obese and non-obese survivors.
|
Academic Article
|
Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome.
|
Academic Article
|
Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.
|
Academic Article
|
A novel 4-cM minimally deleted region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas.
|
Academic Article
|
Trophoblastic pulmonary embolization after hysterectomy for invasive complete mole. A case report.
|
Academic Article
|
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.
|
Academic Article
|
Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.
|
Academic Article
|
Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer.
|
Academic Article
|
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
|
Academic Article
|
Cyclin E deregulation alters the biologic properties of ovarian cancer cells.
|
Academic Article
|
Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
|
Academic Article
|
Risk factors for young premenopausal women with endometrial cancer.
|
Academic Article
|
Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy.
|
Academic Article
|
Gynecologic Cancers in Lynch Syndrome/HNPCC.
|
Academic Article
|
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
|
Academic Article
|
Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
|
Academic Article
|
Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
|
Academic Article
|
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
|
Academic Article
|
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
|
Academic Article
|
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
|
Academic Article
|
Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma.
|
Academic Article
|
Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
|
Academic Article
|
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
|
Academic Article
|
Supracervical hysterectomy in patients with advanced epithelial ovarian cancer.
|
Academic Article
|
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.
|
Academic Article
|
Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
|
Academic Article
|
Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia.
|
Academic Article
|
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
|
Academic Article
|
Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
|
Academic Article
|
Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.
|
Academic Article
|
Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
|
Academic Article
|
BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
|
Academic Article
|
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
|
Academic Article
|
Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.
|
Academic Article
|
Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.
|
Academic Article
|
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
|
Academic Article
|
Limited public knowledge of obesity and endometrial cancer risk: what women know.
|
Academic Article
|
Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.
|
Academic Article
|
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
|
Academic Article
|
MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
|
Academic Article
|
Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges.
|
Academic Article
|
Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
|
Academic Article
|
Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome.
|
Academic Article
|
Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.
|
Academic Article
|
Development of a multimarker assay for early detection of ovarian cancer.
|
Academic Article
|
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.
|
Academic Article
|
FATS is a transcriptional target of p53 and associated with antitumor activity.
|
Academic Article
|
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
Academic Article
|
Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer.
|
Academic Article
|
Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
|
Academic Article
|
Cancer risk management decisions of women with BRCA1 or BRCA2 variants of uncertain significance.
|
Academic Article
|
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
|
Academic Article
|
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
|
Academic Article
|
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.
|
Academic Article
|
Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.
|
Academic Article
|
Genetic risk and gynecologic cancers.
|
Academic Article
|
Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO.
|
Academic Article
|
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
Academic Article
|
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age.
|
Academic Article
|
Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.
|
Academic Article
|
Management of endometrial precancers.
|
Academic Article
|
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
|
Academic Article
|
Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.
|
Academic Article
|
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
|
Academic Article
|
Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening.
|
Academic Article
|
Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.
|
Academic Article
|
Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.
|
Academic Article
|
Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.
|
Academic Article
|
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.
|
Academic Article
|
Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
|
Academic Article
|
Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.
|
Academic Article
|
Early cervical cancer.
|
Academic Article
|
Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.
|
Academic Article
|
Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
|
Academic Article
|
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
|
Academic Article
|
Does a BRCA mutation plus tamoxifen equal hysterectomy?
|
Academic Article
|
Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
|
Academic Article
|
Gynecologic cancers associated with Lynch syndrome/HNPCC.
|
Academic Article
|
Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.
|
Academic Article
|
Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning.
|
Academic Article
|
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
|
Academic Article
|
Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
|
Academic Article
|
Sex hormone regulation of survivin gene expression.
|
Academic Article
|
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.
|
Academic Article
|
Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.
|
Academic Article
|
Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.
|
Academic Article
|
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.
|
Academic Article
|
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
|
Academic Article
|
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
|
Academic Article
|
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
|
Academic Article
|
Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
|
Academic Article
|
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
|
Academic Article
|
Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.
|
Academic Article
|
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
|
Academic Article
|
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
|
Academic Article
|
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
|
Academic Article
|
A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.
|
Academic Article
|
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
|
Academic Article
|
Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.
|
Academic Article
|
Risk of ovarian cancer and the NF-?B pathway: genetic association with IL1A and TNFSF10.
|
Academic Article
|
Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.
|
Academic Article
|
Regional distribution of hypothalamic luteinizing hormone-releasing hormone in proestrous rats: effects of ovariectomy and estrogen replacement.
|
Academic Article
|
[Clinical application of an axial temporal fascia flap with or without scalp].
|
Academic Article
|
[Application of microsurgery in repair of acute traumatic wounds: report of 10 cases].
|
Academic Article
|
Paclitacxel and carboplatin in advanced non-small-cell lung cancer.
|
Academic Article
|
In vitro embryo production in buffalo (Bubalus bubalis) using sexed sperm and oocytes from ovum pick up.
|
Academic Article
|
Membrane progestin receptor beta (mPR-beta): a protein related to cumulus expansion that is involved in in vitro maturation of pig cumulus-oocyte complexes.
|
Academic Article
|
Gynecologic cancer screening and communication with health care providers in women with Lynch syndrome.
|
Academic Article
|
Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome.
|
Academic Article
|
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.
|
Academic Article
|
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus.
|
Academic Article
|
The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline.
|
Academic Article
|
Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer.
|
Academic Article
|
EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
|
Academic Article
|
Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.
|
Academic Article
|
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
|
Academic Article
|
Reply to D. Braun et al.
|
Academic Article
|
Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors.
|
Academic Article
|
A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
|
Academic Article
|
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.
|
Academic Article
|
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
|
Academic Article
|
Clearer picture of PMS2-associated lynch syndrome is emerging.
|
Academic Article
|
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
|
Academic Article
|
Salpingectomy as a means to reduce ovarian cancer risk.
|
Academic Article
|
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.
|
Academic Article
|
Antecedents and mediators of physical activity in endometrial cancer survivors: Increasing physical activity through steps to health.
|
Academic Article
|
Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.
|
Academic Article
|
Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.
|
Academic Article
|
One size may not fit all: the debate of universal tumor testing for Lynch syndrome.
|
Academic Article
|
Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
|
Academic Article
|
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
|
Academic Article
|
Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.
|
Academic Article
|
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
|
Academic Article
|
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
|
Academic Article
|
Management of nodal recurrences of endometrial cancer with IMRT.
|
Academic Article
|
Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor.
|
Academic Article
|
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
|
Academic Article
|
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
|
Academic Article
|
Symposium on advances in endometrial cancer epidemiology and biology.
|
Academic Article
|
The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
|
Academic Article
|
Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
|
Academic Article
|
Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers.
|
Academic Article
|
Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database.
|
Academic Article
|
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
|
Academic Article
|
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
|
Academic Article
|
Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review.
|
Academic Article
|
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
|
Academic Article
|
Long non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrations.
|
Academic Article
|
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
|
Academic Article
|
Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer.
|
Academic Article
|
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
|
Academic Article
|
Survivors of gynecologic malignancies: impact of treatment on health and well-being.
|
Academic Article
|
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers.
|
Academic Article
|
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
|
Academic Article
|
On-Site Fertility Preservation Services for Adolescents and Young Adults in a Comprehensive Cancer Center.
|
Academic Article
|
Sexual health of endometrial cancer survivors before and after a physical activity intervention: A retrospective cohort analysis.
|
Academic Article
|
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
Academic Article
|
A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers.
|
Academic Article
|
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
|
Academic Article
|
[Application of multiple tissue expanders for repair of facial and neck scar].
|
Academic Article
|
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
|
Academic Article
|
Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.
|
Academic Article
|
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.
|
Academic Article
|
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
|
Academic Article
|
Role of Video-Assisted Thoracoscopy in Advanced Ovarian Cancer: A Literature Review.
|
Academic Article
|
Stability of the cytoskeleton of matured buffalo oocytes pretreated with cytochalasin B prior to vitrification.
|
Academic Article
|
Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
|
Academic Article
|
Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
|
Academic Article
|
Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.
|
Academic Article
|
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
|
Academic Article
|
Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
|
Academic Article
|
Endometrial Cancer Associated Symptoms: A Case-Control Study.
|
Academic Article
|
Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer.
|
Academic Article
|
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
|
Academic Article
|
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
|
Academic Article
|
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
|
Academic Article
|
Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.
|
Academic Article
|
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.
|
Academic Article
|
Towards value-based universal Lynch syndrome identification in endometrial cancer patients.
|
Academic Article
|
Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia.
|
Academic Article
|
Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters.
|
Academic Article
|
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.
|
Academic Article
|
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
|
Academic Article
|
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
|
Academic Article
|
Genetic predisposition in gynecologic cancers.
|
Academic Article
|
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.
|
Academic Article
|
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
|
Academic Article
|
Role of Fallopian Tubes in the Development of Ovarian Cancer.
|
Academic Article
|
Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
|
Academic Article
|
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
|
Academic Article
|
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition.
|
Academic Article
|
A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
|
Academic Article
|
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
|
Academic Article
|
Factors prognostic of survival in advanced-stage uterine serous carcinoma.
|
Academic Article
|
Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer.
|
Academic Article
|
Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma.
|
Academic Article
|
Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer.
|
Academic Article
|
Endometrial cancer survivors' sleep patterns before and after a physical activity intervention: A retrospective cohort analysis.
|
Academic Article
|
Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer.
|
Academic Article
|
Screening for Ovarian Cancer in Asymptomatic Women.
|
Academic Article
|
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.
|
Academic Article
|
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
|
Academic Article
|
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
|
Academic Article
|
Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
|
Academic Article
|
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
|
Academic Article
|
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.
|
Academic Article
|
Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes.
|
Academic Article
|
Disparities in treatment and survival among elderly ovarian cancer patients.
|
Academic Article
|
Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness.
|
Academic Article
|
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
|
Academic Article
|
Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice.
|
Academic Article
|
Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.
|
Academic Article
|
KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.
|
Academic Article
|
Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.
|
Academic Article
|
Prognostic factors impacting survival in early stage uterine carcinosarcoma.
|
Academic Article
|
Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection.
|
Academic Article
|
Disparities in gynecologic cancer genetics evaluation.
|
Academic Article
|
Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic.
|
Academic Article
|
U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis.
|
Academic Article
|
National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.
|
Academic Article
|
Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery.
|
Academic Article
|
Women's preferences for cancer risk management strategies in Lynch syndrome.
|
Academic Article
|
Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis.
|
Academic Article
|
Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
|
Academic Article
|
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
|
Academic Article
|
Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
|
Academic Article
|
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
|
Academic Article
|
Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.
|
Academic Article
|
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
|
Academic Article
|
Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review.
|
Academic Article
|
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
|
Academic Article
|
Rapidly Changing Landscape of Fallopian Tube Carcinoma.
|
Academic Article
|
Novel Approaches to Ovarian Cancer Screening.
|
Academic Article
|
Uterine Cancer: Adjuvant Therapy and Management of Metastatic Disease.
|
Academic Article
|
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study.
|
Academic Article
|
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
|
Academic Article
|
Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment.
|
Academic Article
|
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus.
|
Academic Article
|
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
|
Academic Article
|
Unanswered Questions in High-Risk Women Undergoing Risk-Reducing Salpingo-oophorectomy.
|
Academic Article
|
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
|
Academic Article
|
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.
|
Academic Article
|
BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
|
Academic Article
|
National trends in bowel and upper abdominal procedures in ovarian cancer surgery.
|
Academic Article
|
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment.
|
Academic Article
|
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
|
Academic Article
|
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
|
Academic Article
|
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
|
Academic Article
|
Biomarkers and Strategies for Early Detection of Ovarian Cancer.
|
Academic Article
|
Endometrial Cancer.
|
Academic Article
|
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.
|
Academic Article
|
Facilitated cascade testing (FaCT): a randomized controlled trial.
|
Academic Article
|
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer.
|
Academic Article
|
Endometrial Cancer. Reply.
|
Academic Article
|
Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
|
Academic Article
|
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
|
Academic Article
|
Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer.
|
Academic Article
|
Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer.
|
Academic Article
|
Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells.
|
Academic Article
|
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer.
|
Academic Article
|
Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery.
|
Academic Article
|
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.
|
Academic Article
|
Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications.
|
Academic Article
|
Long-term survival following definitive radiation therapy for recurrence or oligometastases in gynecological malignancies: A landmark analysis.
|
Academic Article
|
Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
|
Academic Article
|
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.
|
Academic Article
|
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification.
|
Academic Article
|
Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data.
|
Academic Article
|
Ryanodine receptor 1-mediated Ca2+ signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes.
|
Academic Article
|
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses.
|
Academic Article
|
Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.
|
Academic Article
|
Patient Engagement With Early Stage Advance Care Planning at a Comprehensive Cancer Center.
|
Academic Article
|
Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
|
Academic Article
|
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.
|
Academic Article
|
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.
|
Academic Article
|
Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
|
Academic Article
|
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
|
Academic Article
|
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
|
Academic Article
|
Transforming ovarian cancer care by targeting minimal residual disease.
|
Academic Article
|
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
|
Academic Article
|
Normal Risk Ovarian Screening Study: 21-Year Update.
|
Academic Article
|
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
|
Academic Article
|
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
|